These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 16843668

  • 21. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A, López de Ceráin A, Ezpeleta O, Cerecetto H, Dias E, Di Maio R, González M, Onetto S, Seoane G, Suescun L, Mariezcurrena R.
    Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
    [Abstract] [Full Text] [Related]

  • 22. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI, Scherbakov AM, Dezhenkova LG, Bykov EE, Solovieva SE, Korlukov AA, Sorokin DV, Monzote Fidalgo L, Shchekotikhin AE.
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [Abstract] [Full Text] [Related]

  • 23. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA.
    J Med Chem; 1996 Jun 21; 39(13):2518-28. PubMed ID: 8691449
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
    Moorthy NS, Karthikeyan C, Trivedi P.
    J Enzyme Inhib Med Chem; 2010 Jun 21; 25(3):394-405. PubMed ID: 20233012
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P, Carta A, Loriga M, Vitale G, Paglietti G.
    Eur J Med Chem; 2009 Apr 21; 44(4):1579-91. PubMed ID: 18774202
    [Abstract] [Full Text] [Related]

  • 31. Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.
    Hay MP, Hicks KO, Pchalek K, Lee HH, Blaser A, Pruijn FB, Anderson RF, Shinde SS, Wilson WR, Denny WA.
    J Med Chem; 2008 Nov 13; 51(21):6853-65. PubMed ID: 18847185
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH, Wilson WR, Ferry DM, van Zijl P, Pullen SM, Denny WA.
    J Med Chem; 1996 Jun 21; 39(13):2508-17. PubMed ID: 8691448
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V, Moreau S, Belisle-Fabre S, Thiolat D, Uranga J, Lucas R, de Moor L, Massip S, Jarry C, Mossalayi DM, Sonnet P, Déléris G, Guillon J.
    J Enzyme Inhib Med Chem; 2011 Oct 21; 26(5):657-67. PubMed ID: 21250818
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
    Moarbess G, Deleuze-Masquefa C, Bonnard V, Gayraud-Paniagua S, Vidal JR, Bressolle F, Pinguet F, Bonnet PA.
    Bioorg Med Chem; 2008 Jul 01; 16(13):6601-10. PubMed ID: 18513976
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
    Hu Y, Xia Q, Shangguan S, Liu X, Hu Y, Sheng R.
    Molecules; 2012 Aug 13; 17(8):9683-96. PubMed ID: 22890172
    [Abstract] [Full Text] [Related]

  • 39. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
    Siim BG, Atwell GJ, Anderson RF, Wardman P, Pullen SM, Wilson WR, Denny WA.
    J Med Chem; 1997 Apr 25; 40(9):1381-90. PubMed ID: 9135035
    [Abstract] [Full Text] [Related]

  • 40. Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.
    Weng Q, Wang D, Guo P, Fang L, Hu Y, He Q, Yang B.
    Eur J Pharmacol; 2008 Mar 10; 581(3):262-9. PubMed ID: 18215659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.